Mucosal Ablation in Patients with Barrett’s Esophagus: Fry or Freeze?

Kavel Visrodia, Liam Zakko, Kenneth Ke Ning Wang

Research output: Contribution to journalArticle

3 Scopus citations


The management of Barrett’s esophagus and early esophageal adenocarcinoma has shifted away from esophagectomy and toward endoscopic techniques, including endoscopic resection and ablative therapies. The most commonly used ablative therapies are radiofrequency ablation and cryotherapy. Radiofrequency ablation has risen to the top of the management algorithm due to its favorable safety profile and established track record of efficacy in patients with dysplastic Barrett’s. Cryotherapy offers early promise as an alternatively safe and effective ablative modality. We review radiofrequency ablation and cryotherapy techniques, and updated data regarding their efficacy and safety as well as their roles in the management of Barrett’s esophagus.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalDigestive Diseases and Sciences
StateAccepted/In press - May 17 2018


  • Barrett’s esophagus
  • Cryoablation
  • Cryotherapy
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Mucosal Ablation in Patients with Barrett’s Esophagus: Fry or Freeze?'. Together they form a unique fingerprint.

  • Cite this